Study of Dosage Individualisation for the Treatment of Acute Myeloid Leukemia

M

Mikkel Krogh-Madsen

Status

Completed

Conditions

Acute Myeloid Leukemia

Treatments

Other: PK-PD analysis

Study type

Observational

Funder types

Other

Identifiers

NCT00969891
AMLPKPD-20081127
EudraCT nummer 2008-008165-35

Details and patient eligibility

About

The present study is not hypothesis driven but will explore the ability of pharmacokinetic-pharmacodynamic modelling to predict optimal dosage of the chemotherapeutic drugs used in therapy in adult patients with acute myeloid leukemia.

Enrollment

23 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

adult men and women with newly diagnosed acute myeloid leukemia

Exclusion criteria

under age 18 years

Trial design

23 participants in 1 patient group

AML patients in induction treatment
Treatment:
Other: PK-PD analysis

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems